Welcome to the CBIZ first quarter results conference call. My name is Terice, and I will be your operator for today’s call. At this time all participants are in a listen-only mode. Later we will conduct a question-and-answer session. Please note that this conference is being recorded. I will now turn the call over to Mr. Steven Gerard. Mr. Gerard you may begin.

Thank you Terice, and good morning everyone. Thank you for calling in to CBIZ’s first quarter 2010 conference call. Before I begin my comments, I’d like to remind you of a few things. As with all of our conference calls, this call is intended to answer the questions of our share holders and analysts. If there are media representatives on the call, you are welcome to listen in; however, I ask that if you have questions you hold them until after the call and we’ll be happy to discuss it at that time. The call is also being webcast and you can access the call over our website at www.cbiz.com. You should have all received a copy of the press release we issued this morning. If you did not, you can access it on our website or you can call our corporate office for a copy. Finally, please remember that during the course of the call, we may make forward-looking statements. These statements represent management’s intentions, hopes, beliefs, expectations, and predictions of the future. Actual results can and sometimes do differ materially from those projected in the forward-looking statements. Additional information concerning the factors that could cause actual results to differ materially from those in the forward-looking statements is contained in our SEC filings Form 10-K and press releases. Joining me on the call this morning are Jerry Grisko, our President and Chief Operating Officer; and Ware Grove, our Chief Financial Officer. As you all know, prior to the opening this morning we released our first quarter earnings. We released earnings per share of $0.27, which includes a $0.02 charge for the previously announced write-off of lease expense as a result of one of our acquisitions. So as you normalize the two, we reported $0.29 versus $0.30 a year ago on somewhat lower revenue. On the positive note, with lower revenue our cash earnings per share were equal to last year, and on an equally positive note, our two largest groups, our financial services group and employee services group, both performed better on the bottom line, given the fact that their revenue was down. I will have a number of comments to add to Ware’s presentation with respect to our MMP business, as well as a status of other items in the company, but at this point I’ll turn it over to Ware to go through the details.

Thank you Steve, and good morning everyone. As is our normal practice, I want to take a few minutes to review the highlights and add perspective to the numbers we released this morning for the first quarter 2010 results. I should first remind everyone that 2009 numbers are now restated for the impact of the discontinued operations that occurred in the fourth quarter of 2009. You can find further detail on that in our 10-K filing footnote number 22, which is on S-43, and I believe we also filed some supplemental quarterly information with our 8-K in connection with the year-end earnings release, but I’m happy to provide in the follow up questions any further details that anyone needs. There are a number of favorable trends impacting our business at this stage, but as we indicated earlier this year, we expected that 2010 would present a challenging environment for CBIZ, and we therefore expected a relatively modest growth in revenue and earnings for the full year. While we are all aware of the reported improvements and economic growth in recent quarters, unemployment levels continue to be high, and through the first quarter of 2010 we have not yet seen a general rebound in activity within the small and mid size business client, that is typically served by CBIZ. There are recent indications that investment spending and expansion activity within the CBIZ client base is beginning to improve, but our first quarter same unit revenue decline of 5.6% reflects continuing pressures within this market segment that we serve. This decline in revenue for the first quarter was not totally unexpected. Bear in mind that the same unit revenue declines we experienced in the second half of 2009 were 7% and 9.1% in the third and fourth quarters of 2009. So sequentially…

Thank you, Ware. Let me give you some more information with respect to our medical management business, given that was the primary reason for the decline in the quarter. 70% of our doctor groups witnessed a decline in total number of procedures. On an aggregate basis the total number of procedures that we performed were down 8.4%, with radiology being down 10.3%. When you consider that in the quarter, last year we did over 7 million procedures, we are talking about a decline in procedures of over 600,000 quarter-to-quarter. Equally or perhaps more important as Ware pointed out, the high modality procedures, those that get charged the most which are your CAT scans, your MRIs, your diagnostic exams, and your mammography were down and estimated 10% to 12% across the board. As Ware also points out, these numbers are consistent with what we are seeing in both public companies and in the private companies we talk to. The reasons are not clear. They are in part weather, they are in part on employment, they are in part the shift to more and more people with high deductible plans, which means they are going to do less of the high procedures using their own money in the first quarter. They are probably influenced by the congressional review of self referrals and probably influenced by the new healthcare bill which has in it, information concerning multiple procedures given to patients on the same day, which is an issue that will come out in the future. The combination of all of these has caused less procedures, and until we get more clarity as to exactly why, we can only surmise the reason. Bottom line was procedures were down 8.4%, and that was in part due to the fact that we had lost some…

Thank you. (Operator Instructions) And our first question comes from Josh Vogel; please go ahead. Josh Vogel – Sidoti & Co.: Hey good morning Stephen and Ware, thanks for taking my questions. Thanks for all the detail with regards to MMP, but I was just curious. You note that if the volume of the procedures returns to normal levels, you are comfortable with your full year EPS guidance, but I was curious to how soon this would have to return to normal levels in order for you to leave the guidance intact.

That’s a very good question Josh. We monitor this month-to-month. We have an extraordinary amount of detail down to the client level. It’s unclear at this point; we are not prepared to make any change at this point, and I can’t at this point tell you. We probably would know by the end of this second quarter whether the trends in both total procedures and in modality continue, and would probably be in a better chance at that time to determine whether or not the full year bottom line guidance should be adjusted. Josh Vogel – Sidoti & Co.: Okay, can you give any sort of commentary as to the number of procedures they saw in April relative to January, February and March?

We are just massing the April data now. Appreciate we have over 400 clients in 70 locations and on somewhat different systems, because we have four different types of medical services. We don’t have that data at this point. We also have to go back and look at the number of days and the month compared to the prior April of last year. So we are in the process of doing that now, but I think that the right time for us to be reexamining the impact on full year probably would be with a couple of more months of information. Josh Vogel – Sidoti & Co.: Okay, and I’m sorry, just one more with regard to MMP. Can you just talk about the monthly trends that you saw January through March, in terms of the numbers of procedures.

I think the trends were generally down, maybe not totally conclusive, because again, as opposed to losing a client where you know what the revenue impact is, what we end up seeing is less procedures from a whole lot of different clients. So I think we saw trends coming down in the quarter for sure, primarily in the radiology where we were off 10% quarter-over-quarter. Josh Vogel – Sidoti & Co.: Okay, shifting to National practices, do you feel that there is more business divisions here that you plan to get out of, and you know if so, what do you think the revenue impacts would be there?

No the businesses that are remaining in national practices at this point, which consists primarily of our Edward Jones support business, and our healthcare consulting business in New Jersey, are both businesses that we intend to keep and I expect that they will do just fine as they have in each of the other years. So there are no other planned dispositions out of national practices. Josh Vogel – Sidoti & Co.: Okay great, and just lastly, what were the total earn out payments in the quarter, and are there any others planned for the rest of the year?

Hi Josh. This is Ware. As I indicated we spend about $26 million, about half of that was earn out, and half of it was closing payments for the new acquired businesses. So for the total year 2009, we probably have another 12 or so to go in terms of future payments. Then if your question is in 2010, we have about $22 million $ 23 million planned, assuming people hit their full target, and about $20 million planned in 2011. Josh Vogel – Sidoti & Co.: Perfect. Alright, thank you very much.

Josh, let me add one other point about MMP for your information as well as everybody else. MMP is a business we acquired in 1998 doing $18 million of revenue. Last year it did $160 million of revenue. It is been a good strong growing business for us. Unlike any business that has had that kind of growth, it’s going to have a bump in the road from time to time. But it is a business that we are going to continue to invest in, and grow, because we believe that the long term trend is going to be for more and more doctor groups, especially in our specialties, to continue to have a third party do their billing. So we see a long term positive growth scenario here, once we get through figuring out what happened this year, and quite frankly the last half of last year.

Thank you. Our next question comes from Garry Movitz; please go ahead. Garry Movitz – Unidentified Company: Good morning guys. I wanted to ask couple of questions on the MMP also. I guess first, how did numbers that you gave from a procedure standpoint compare to maybe like the third and fourth quarter of last year.

Garry I don’t have that in front of me, but we can get that because we do know quarterly our procedures. I have just in front of me the quarter-over-quarter, first quarter versus first quarter but I would he happy to get you that. Garry Movitz – Unidentified Company: Okay thank you, and then I guess the troubling part of it I think for you also is just the significance to the decline in profitability. It sounds like you have taken some actions even if the procedure account stays lower, that you can hopefully recoup some of that profitability. Is there any kind of metrics you can give us to get us a sense for whether the levels of the declines in the profits, whether they should really reduce somewhat or thoughts on that.

You know, I think that we are in the process now of finishing off all of the other actions that we need to take in response to the decline in revenue, because the decline in revenue tended as I said earlier not to come from the loss of a bunch of clients in one area, where you knew how many people were effected. It tended to be trebled out across the entire portfolio. It was much more difficult to determine where your expense saves were likely to be. We have historically shown the ability to mitigate revenue declines by adjusting our expense base, and I think I am pretty comfortable we’ll be able to do that again as to the exact metrics. We will probably have a lower margin in that business for this year than we have had historically, given the fact that we are a little bit behind the curve in the first quarter, but maybe not dramatically; beyond that, I don’t think we have metrics yet that we can share. Garry Movitz – Unidentified Company: Okay, and then just from the standpoint, it does seem like procedures were down it seems like most of last year. Why did this come as a particular surprise I guess?

I think the surprise for us was in part the procedures, because in past last year the procedures were down in very definable locations, and primarily related to the loss of a specific client. This was much more general across the entire base. But last year we did not see the same extent of the modality change. The most dramatic swing for us this year was a 10% to 12% to 14%, depending on which procedure it is, reduction in the very, very high cost procedures; the MRIs, the CAT scan, Mammography, and the diagnostics. To give you a sense of proportion, those procedures you probably pay us seven to 10 times what the normal scan of a broken arm is going to pay. So what we saw was not only lower procedures but a significant reduction in the high cost procedures which have costs related to the revenue procedures for us. Garry Movitz – Unidentified Company: Got it, all right then last couple of questions; one, is there any way you could take a stab at what you think your guidance would be if procedure counts did stay kind of where they are now?

No it is too soon to do that, because quite frankly as we are pointed out, we are seeing positive, albeit somewhat anecdotal signs in our other businesses, and before we start changing guidance because we get guidance for the whole company, we want to be able to factor that in as well. Garry Movitz – Unidentified Company: And so the organic growth numbers in employer services and financial services, those kind of came in where you figured and the profit seemed pretty good too.

Yes, the revenue is off a little bit as we indicated, but in both of those groups they reported higher revenue year-over-year, a higher earnings contribution year-over-year on lower revenue. So we are more or less comfortable with their performance. Garry Movitz – Unidentified Company: All right. Okay thanks very much. Good luck.

Thank you. Our next question comes from Robert Kirkpatrick; please go ahead.

Thank you. Just a couple of housekeeping questions maybe for Ware. Ware, where would I find the pre-tax restructuring charge and the increased legal expenses when I think about the segment breakdown of your income?

First of all, the legal expenses are in the general and administrative expenses, so they are not included in the segment reports that you see. The restructuring charge that is in that line I think is called corporate unallocated. It’s not attached or allocated to any one protected segment at this stage. So its part of that $4.4 million number that you see there on other corporate unallocated.

Okay and Steve, could you talk a little bit more may be about the M&A market in general. In terms of what are you seeing in terms of your pipeline; how has it changed from last quarter and from a year ago.

I would characterize the pipeline as relatively unchanged from the last quarter and last year. We still have our normal number of attractive financial services companies and our normal number of attractive employee service opportunities. The pricing has not dramatically changed. So again, in the financial services business as a cash buyer, we are still basically the only buyer in the market. On the employee services side, the market itself hasn’t been dramatically changed for the smaller transactions. So I would view the pipeline as a strong as we have seen it before, and I view the pricing to be more or less the same, and as I think you know, we are very disciplined in our approach, so we are not going outside of our traditional margin multiple anyway.

Okay, and then could you comment on the financial services area. You talked about doing less work for your consistent stable of clients. How would you characterize that less work, in particular areas and fields.

Yes, I think it’s certainly on the audit side I think we’ve seen a decline. Interestingly our average pricing for the quarter is up a bit. Our hours were down, and our client retention rates remain the same, which is what drives us to the fact that we are doing less. We are also not able to charge for some things that historically were add-ons that historically we were able to get as well. So I think it’s a combination. It’s not dissimilar from what we saw last year. The financial services environment is pretty consistent in that respect. Our clients have not yet opened up the pocket books to begin to dramatically expand.

I would guess we see both, in to an ADP employment reports starting to look a little bit better than generally realize that hopefully that won’t be too much further down the road.

Well I hope so. Our own payroll business has just reported that they have now seen [Technical Difficulty] because we have so many locations, and because many, many people have multiple functions in those locations, you can see a decline in revenue that doesn’t automatically translate to headcount reductions, which is typically your biggest expense. So you’re locked in a little bit in the short run. Over the long run you can move clients; you have technology opportunities to improve things which we are working on, but yes I mean 70 some odd percent of the cost is in people.

Just bear in mind that the people are coders, and these are trained and certified coders. So it takes those a learning curve and an investment on the part of the company, so not unlike what we’ve described in financial services. We want to be very careful about managing that headcount down too quickly. So yes, we got caught, and there was a big margin squeeze in the first quarter, and we are looking at opportunities to align cost more carefully with revenue, but as we said before, the procedure mix issue is a bit unclear to us right now.

One could assume and should assume that if there is a 10% reduction in procedures for radiology, that overtime we should be able to compensate for that. It’s just not going to happen in a particular quarter.

Okay, and then on the national practices, this being primarily, the Jones contract being slightly above breakeven I think for the quarter. Is that indicative of that type of business or was there something special that went on there during the quarter.

We need to clarify that. There are two business units in there. There is Edward Jones which actually performed better than planned for the quarter, and our medical advisory business in New Jersey which actually performed worse than planned; although I expect that they will make that up. So the number doesn’t reflect anything on the Edward Jones’s contract. We were ahead of what we expected.

All right, thank you so much Steven.

Okay.

Thank you. Our next question comes from the Bill Sutherland; please go ahead. Bill Sutherland - Boenning & Scattergood: Thank you, and good morning. Group health premiums, how are they tracking as far as year-over-year?

What you are seeing is two things. You are continuing to see an increase in the cost of insurance, which means that the premiums are going up, but you are offset by the fact that you have less people in the various groups that are being covered. Bill Sutherland - Boenning & Scattergood: Aren’t you getting to a point where you are sort of anniversarying that part of it.

No I don’t think so. I think the general decline in number of employees started to occur earlier in the year last year, but persisted and got worse throughout the year, so we haven’t a quite lapped that factor. The other factor I think that impacts our revenue is the fact that an employer typically will mitigate premium cost increases with some plan design changes; and that’s not atypical either. So there is not a real linear relationship between our revenue and premium cost changes. Bill Sutherland - Boenning & Scattergood: Okay, that’s good color. The financial service side with a little bit of acquisition impact for the year; based on kind of how you see things trending in the beginning of this quarter. Are you thinking you are going to be able to have revenue growth? I mean it looks like its going to be challenging certainly on a same unit basis.

Yes, I think that’s the way we are looking at it. I think it’s going to be very challenging on a same unit basis. I think with acquisitions we will probably be up for the year, but the market is soft and our clients are not yet opening up to expand to do lots of things that they historically used us for. Bill Sutherland - Boenning & Scattergood: What, particularly surprised me Steve is when you said audits were down, I guess you mean mainly external audits which people don’t have much latitude on to the business to adhere?

No, I think the number of audits we did were less, and I think I know that the number of audits we did were less, and I think you typically had the ability to charge for things that came up in audits that weren’t originally envisioned for, that we don’t have the ability to pass that on. Bill Sutherland - Boenning & Scattergood: Okay, all right, that makes sense. Finally, I know there is a lot of moving pieces in MMP. One of the factors you’ve mentioned in terms of possible explaining procedure decline was decreased self referrals, would you mind elaborating slightly. I’m not sure how that works.

Well, sure. There has been from time-to-time some initiatives in Congress to amend or write laws that would regulate the extent to which doctors could refer patients to facilities they had an economic interest in. That issue came up again in the health care debate. There is a bill or proposal in front of Congressman Waxman’s sub committee, dealing with this issue. My best guess is that, to the extent that this was a contributor, and I can’t tell you the extent it was, but to the extent it was a contributor, it was because a shot was across the bow. The doctors are looking at all of the things coming out the health care debate and trying to figure out that which is going to give him a problem, and that which is not. This is clearly a bill pending now and there will be sub committee discussions on the self referral issue. Bill Sutherland - Boenning & Scattergood: Two questions on that. So you are saying that the physicians who might be impacted or actually just acting prospectively without anything actually in place to drive it?

I’m starting with the statement is that we don’t know the all of the reasons. We are just trying to put together why we think things are happening. There are no real regulations as far as I know about this, but it is under review. So when you take a step back and say “What’s affecting the doctors, why we seeing across the board all of these declines” these are reasons we think is a contributor, and quite frankly I believe that there is an industry bullet on this issue from one of the radiology groups, talking about the fact that doctors are concerned about it. To the extent that that concern has actually migrated to them referring less patients, I don’t know. Bill Sutherland - Boenning & Scattergood: Okay. Well then lastly Steve, you’ve talked just a little bit about some technology enhancements you want to do on MMP, and obviously the importance that it keeps increasing. So may be you can talk a little bit more on that and the timing of that. Thanks.

Sure. That’s a great question and we have a roll out plan for new technology primarily in radiology. That plan has begun. We have slowed it up a little bit to make sure we are doing it right in each place we do it. So the full impact that we expect this year maybe a little bit less, but we are on a three year plan to migrate all of our radiology clients to a new, better processing system, and we’ll be rolling that out over the next two and half years. Bill Sutherland - Boenning & Scattergood: Great thanks.

Thank you. Our next question comes from Vincent Colicchio; please go ahead. Vincent Colicchio – Noble Financial Group: Yes Steve. I was curious -- not to beat the dead horse from the MMP business, but on the competitive landscape I’m wondering if there any changes there of magnitude such as new entrance or aggressive pricing by certain competitors?

No new significant entrance that I am aware of; although there is always some mom and pops that pop up. There has been some aggressive pricing by some of our competitors and we have to react to that, so there has been a revenue impact on our reaction to that. I would say that all of the billing companies are facing exactly what we are facing, which is a larger squeeze with lower revenue and the other markets pretty tough out there. Vincent Colicchio – Noble Financial Group: And one last question, I don’t know if this was answered, do you have any larger renewals coming to you in the current quarter?

I’m sorry large. Vincent Colicchio – Noble Financial Group: Any large renewals, of any kind magnitude coming up for renewal in the current quarter?

You mean renewals with our clients? Vincent Colicchio – Noble Financial Group: Yes.

No. Again, we have 50,000 corporate clients. Other than Edward Jones, we don’t have any client that has any significant any one client that has any significant impact on revenue at all, and there were no normal renewals of there are no abnormal renewals in the next quarter that should impact anything. Vincent Colicchio – Noble Financial Group: Thank you.

Thank you. Our next question comes from Ted Hillenmeyer; please go ahead.

Hey guys. I didn’t catch what you said on the seasonality of receivables. I think you mentioned $3 million versus a norm of $10 million to $12 million?

Yes, what typically happens Ted is in the first quarter driven by the seasonal activity in financial services for audit and tax work, we do the work and the work gets basically recorded in our receivables. Those receivables get paid by clients in the second and third quarter, so we generate cash as those receivables liquidate in the second and third quarter; and that’s been a seasonal pattern here for many years at CBIZ. Typically, because of that we use I’ll say $10 million to $20 million of cash in the first quarter to support that. This year we used approximately $3 million of cash, which tells us that the receivables are generally liquidating as they should to expectations, and quite frankly on the disbursement side because of our focus on managing expenses, we are watching the outflows further carefully as well. We are not differing capital spending or anything like that. It’s fairly nominal in the first quarter, but that’s not unusual.

I’m confused. What caused the difference $3 million versus $10 million to $20 million?

Just the continued focus on the managing of the outflows and the expenses, along with the continued liquidation of the receivables that were booked throughout the fall and second half of 2009. I think we had some small cash balance at the end of the year that we used, $2 million or $3 million, but its just assign that we’re managing the business and particularly the disbursement fairly carefully as we are keeping a close eye on expenses.

When the cash comes in the door in Q2 and Q3, are you saying it’s only going to have a bump up of $3 million or?

No I’m not. It should bump in an excess of that. For the total year we would expect free cash flow of roughly $50 plus million. So in the second and third quarter you might see $15 plus million in each quarter.

Okay, thanks. And then for acquisitions, can you give any color on the size of deals that are potential?

In the financial services group, our most likely acquisitions are of businesses that are anywhere from $10 million to $30 million of revenue. We don’t have anything that I would say is highly likely at this point, because things do change -- there are 50 or more. On employee services side I think there will more traditional smaller transactions, anywhere from $3 million to $10 million.

And then following up on some of the previous questions, the margin squeeze you and the competitors are seeing in MMP, has that prompted anybody to look at selling businesses? If you have any scuttlebutt on that?

I am not aware that of any as a result of what’s effectively been a relatively short term change in everyone’s revenue. I am not aware that anybody is actively looking to sell their business. A number of the billing companies that we compete with are private equity owned, and most of them are probably thinking about expanding before they think about selling, but at this point the change as far as we know hasn’t driven anybody to be a seller.

Okay, and then within MMP you mentioned I think loss of clients in previous quarters. You are saying that that did not accelerate in this quarter and was that partly an attitude change of just not being willing to loose clients and instead giving little on price?

The answer is yes, we did not loose more clients that we gained in the first quarter and we believe that the client loss may have dramatically slow down. What I said in the call in the prior quarter was, what we saw in 2009 was that we lost more accounts, more clients than we booked; and it was the first time I believe in certainly ten years that that occurred. We believe that there are a lot of reasons for that, and most of which was a paralysis caused by the pending health care bill. The doctors group just weren’t making dramatic changes, but we did loose a number of doctor groups. We lost some to competitors, but we lost most of them or we lost a lot of them to the fact that the group just went away. They left their contract, so they broke up or they combined with other groups. That doesn’t seem to have happened in the first quarter, and we don’t believe that that trend of loosing more than we will gain will happen in 2010 based on the size of the new business pipeline.

Or is there a change in the trend of these being within a hospital versus facilities being outside the hospital?

I am not sure I understand the question Ted.

Nor is there a change, if these radiologists are on site within a hospital versus offsite.

And then financial services, kind of the fall off on the one-time projects. Do you know when that kind of kicked in last year? Did you hit a point where you run into easier comps?

While easier comps, yes. Typically the special business comes after the busy season of tax and audit, so what you are really looking at is the second half of the year. Typically what happens in the financial services group is they work very, very, very hard through the mid-April timeframe or the end of April, but then they take some vacation and do their training or whatever. So the special business really impacts you, second half of the year. So to the extent we will have favorable comps over unfavorable performance, it will be in the second half of the year.

And I don’t know if I heard you mention, the Employee Services was up 3%, down 1.6 same store, but the operating income or gross margin was up 20%. What drove that big positive leverage?

I think as you imply the impact from the newly acquired business certainly was good and positive and in line with our expectations generally speaking, but the expense leverage, the control on expenses was favorable this year versus last year. So as we did in financial services we were able to improve margins on a slight decline in revenue this year on the same unit basis.

Okay, I think that’s all I got. Thanks.

Thank you. Our last question comes from Robert Kirkpatrick, please go ahead.

Thank you. Just a quick follow-up, have you seen any change in your need to take provisions for bad debts this year compared with last year.

No, actually as I noted, the expense there is slightly less than it was a year ago. We look at receivables, and particularly the aged receivables every month and we have a healthy review process. This year we are at about 51 basis points compared to about, what I say 80 basis points a year ago. So even with a slight degradation in DSOs, we think the ability for clients to pay is improving somewhat.

Great, thank you so much, I appreciate it.

Thank you. We have no further questions at this time.

I would like to thank everyone who has called in. Obviously, the first quarter was a bit of a disappointment to us primarily as a result of our, what we’ve explained from our medical practice business, as I’ve indicated it is a good fundamental business and we will be working very hard to make sure we right size and get it back on the growth path that it has historically been on. To the CBIZ employees who are listening in, our financial services and employee services groups did very well given a troubled environment and we are appreciative of that, and I look forward to addressing everyone after the second quarter numbers. Thank you.

Thank you ladies and gentlemen, this concludes today’s conference. Thank you for participating, you may now disconnect. Thank you.